KBC Group NV - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 297 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.3%.

Quarter-by-quarter ownership
KBC Group NV ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$320.0%9050.0%0.00%
Q2 2023$32
-100.0%
905
-58.7%
0.00%
Q1 2022$101,000
-39.2%
2,192
-17.4%
0.00%
-100.0%
Q3 2021$166,000
-62.3%
2,655
-50.0%
0.00%0.0%
Q2 2021$440,000
+25.0%
5,3100.0%0.00%0.0%
Q1 2021$352,000
-84.3%
5,3100.0%0.00%0.0%
Q4 2020$2,241,000
+509.0%
5,310
-37.7%
0.00%0.0%
Q3 2020$368,000
+1169.0%
8,530
+2032.5%
0.00%
Q2 2020$29,0004000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders